Skip to content

The role of Vitamin D-assisted patient-controlled intravenous analgesia in acute and chronic pain after thoracic surgery: a prospective, randomized, double-blind, placebo-controlled study

The role of Vitamin D-assisted patient-controlled intravenous analgesia in acute and chronic pain after thoracic surgery: a prospective, randomized, double-blind, placebo-controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069913
Enrollment
Unknown
Registered
2023-03-29
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute and chronic pain after thoracic surgery

Interventions

The experimental group:Vitamin D2 600000iu (3ml) was injected intramuscularly before operation, once every half a month and supplemented for 3 months
The control group:normal saline(3ml) was injected intramuscularly before operation, once every half a month and supplemented for 3 months

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) age>= 18 years old, < 65 years old; (2) patients undergoing thoracotomy or thoracoscopic pneumonectomy under general anesthesia; (3) voluntarily participate in this study and sign informed consent

Exclusion criteria

Exclusion criteria: (1) patients with chronic pain (> 3 months) before operation; (2) unable to communicate due to coma, severe dementia, language disorder or end-stage disease before operation; (3) patients with severe disease (ASA >= grade IV), severe renal insufficiency (preoperative dialysis), severe liver insufficiency (chlid Pugh grade C), parathyroid disease, hypercalcemia (Ca2 + > 2.75 mmol / L), hyperphosphatemia (P > 1.62 mmol / L), history of gastric bypass surgery and urinary calculi; (4) patients who used analgesics, nonsteroidal drugs, vitamin D supplements and thiazides for a long time before operation; (5) patients with severe cardiovascular disease before operation; (6) participated in another trial that may affect vitamin D research; (7) patients with postoperative wound infection; (8) patients who refused to participate in the study

Design outcomes

Primary

MeasureTime frame
Incidence of chronic pain 12 weeks after operation;

Secondary

MeasureTime frame
Dosage of opioids for intravenous analgesia within 96 hours after operation;The degree and incidence of chronic pain 6 months and 1 year after operation;Scores of sleep, anxiety and depression at 4 weeks, 8 weeks, 12 weeks, 6 months and 1 year after operation;health status score at 4 weeks, 8 weeks, 12 weeks, 6 months and 1 year after operation;Survival rate and recurrence rate within 1 year after operation;

Countries

China

Contacts

Public ContactLiao Qin

The Third Xiangya Hospital of Central South University

lincoln0221@csu.edu.cn+86 139 7586 3943

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026